4//SEC Filing
Jeanmonod Patrik 4
Accession 0001209191-23-059819
CIK 0001831915other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 5:36 PM ET
Size
5.6 KB
Accession
0001209191-23-059819
Insider Transaction Report
Form 4
Jeanmonod Patrick
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-12-26$9.50/sh−3,000$28,500→ 93,400 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.48 to $9.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Cytek Biosciences, Inc.
CIK 0001831915
Entity typeother
Related Parties
1- filerCIK 0001873085
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 5:36 PM ET
- Size
- 5.6 KB